US20120116496A1 - Stent structures for use with valve replacements - Google Patents

Stent structures for use with valve replacements Download PDF

Info

Publication number
US20120116496A1
US20120116496A1 US13/286,407 US201113286407A US2012116496A1 US 20120116496 A1 US20120116496 A1 US 20120116496A1 US 201113286407 A US201113286407 A US 201113286407A US 2012116496 A1 US2012116496 A1 US 2012116496A1
Authority
US
United States
Prior art keywords
stent
region
proximal
closed cells
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/286,407
Other languages
English (en)
Inventor
Timothy A. Chuter
Blayne A. Roeder
Sharath Gopalakrishnamurthy
Alan R. Leewood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Medical Technologies LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45444504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20120116496(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US13/286,407 priority Critical patent/US20120116496A1/en
Application filed by Individual filed Critical Individual
Assigned to COOK MEDICAL TECHNOLOGIES LLC reassignment COOK MEDICAL TECHNOLOGIES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHUTER, TIMOTHY A.
Assigned to COOK MEDICAL TECHNOLOGIES LLC reassignment COOK MEDICAL TECHNOLOGIES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC.
Assigned to MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC. reassignment MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOPALAKRISHNAMURTHY, SHARATH, LEEWOOD, ALAN R., ROEDER, BLAYNE A.
Publication of US20120116496A1 publication Critical patent/US20120116496A1/en
Priority to US15/841,744 priority patent/US10695171B2/en
Priority to US16/913,434 priority patent/US11554011B2/en
Priority to US16/913,472 priority patent/US11602428B2/en
Priority to US18/154,573 priority patent/US11911270B2/en
Priority to US18/587,117 priority patent/US12245936B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008—Fixation appliances for connecting prostheses to the body
    • A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017—Angular shapes
    • A61F2230/0019—Angular shapes rectangular
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063—Three-dimensional shapes
    • A61F2230/0073—Quadric-shaped
    • A61F2230/0078—Quadric-shaped hyperboloidal

Definitions

  • the present embodiments relate to implantable medical devices, and more particularly to an implantable medical device for the repair of a damaged endoluminal valve, such as an aortic valve.
  • the aortic valve functions as a one-way valve between the heart and the rest of the body. Blood is pumped from the left ventricle of the heart, through the aortic valve, and into the aorta, which in turn supplies blood to the body. Between heart contractions the aortic valve closes, preventing blood from flowing backwards into the heart.
  • Damage to the aortic valve can occur from a congenital defect, the natural aging process, and from infection or scarring. Over time, calcium may build up around the aortic valve causing the valve not to open and close properly. Certain types of damage may cause the valve to “leak,” resulting in “aortic insufficiency” or “aortic regurgitation.” Aortic regurgitation causes extra workload for the heart, and can ultimately result in weakening of the heart muscle and eventual heart failure.
  • aortic valve After the aortic valve becomes sufficiently damaged, the valve may need to be replaced to prevent heart failure and death.
  • One current approach involves the use of a balloon-expandable stent to place an artificial valve at the site of the defective aortic valve.
  • Another current approach involves the positioning of an artificial valve at the site of the aortic valve using a self-expanding stent.
  • the normal aortic valve functions well because it is suspended from above through its attachment to the walls of the coronary sinus in between the coronary orifices, and it has leaflets of the perfect size and shape to fill the space in the annulus. However, these features may be difficult to replicate with an artificial valve.
  • the size of the implantation site depends on the unpredictable effects of the balloon dilation of a heavily calcified native valve and its annulus. Poor valve function with a persistent gradient or regurgitation through the valve may result.
  • different radial force considerations may be needed at the different locations for the prosthesis to optimally interact with a patient's anatomy. Still further, it is important to reduce or prevent in-folding or “prolapse” of an artificial valve after implantation, particularly during diastolic pressures.
  • the present embodiments provide a medical device for implantation in a patient.
  • the medical device comprises a stent and a valve.
  • the stent comprises a proximal region comprising a cylindrical shape having a first outer diameter when the stent is in an expanded state, and a distal region comprising a cylindrical shape having a second outer diameter when the stent is in the expanded state.
  • the second outer diameter is greater than the first outer diameter.
  • a plurality of closed cells are disposed around the perimeter of the proximal region of the stent, and another plurality of closed cells are disposed around the perimeter of the distal region of the stent.
  • An overall length of each of the closed cells of the proximal region of the stent is less than an overall length of each of the closed cells of the distal region of the stent when the stent is in the expanded state.
  • the stent further comprises a tapered region disposed between the proximal and distal regions.
  • the tapered region transitions the stent from the first diameter to the second diameter.
  • the tapered region further comprises a plurality of closed cells. An overall length of each of the closed cells of the tapered region is greater than the overall length of each of the closed cells of the proximal region and less than the overall length of each of the closed cells of the distal region when the stent is in the expanded state.
  • a proximal region of the valve is at least partially positioned within the proximal region of the stent, and the distal region of the valve is at least partially positioned within one of the tapered and distal regions of the stent.
  • the proximal region of the stent and the proximal region of the valve are aligned with a native valve, and the distal region of the valve is distally spaced-apart from the native valve.
  • FIGS. 1-2 are, respectively, side and perspective views of an exemplary stent to structure in an expanded state.
  • FIG. 3 is a side view illustrating the stent structure of FIGS. 1-2 in a compressed state.
  • FIG. 4 is a side view of an exemplary integral barb of the stent structure of FIGS. 1-2 .
  • FIGS. 5-6 are perspective views of an exemplary aortic valve when no forces are imposed upon the valve.
  • FIG. 7 is a perspective view the aortic valve of FIGS. 5-6 during systole.
  • FIGS. 8-9 are side views illustrating a technique for coupling the aortic valve of FIGS. 5-7 to the stent structure of FIGS. 1-3 .
  • FIG. 10 is a schematic showing the aortic prosthesis of FIG. 9 disposed within a patient's anatomy.
  • FIGS. 11-12 are, respectively, perspective views of an aortic valve comprising suspension ties when no forces are imposed and during diastole.
  • FIG. 13 is a side view illustrating coupling of the aortic valve of FIGS. 11-12 to the stent structure of FIGS. 1-3 .
  • FIGS. 14-16 are, respectively, perspective views illustrating an aortic valve comprising reinforcement strips when no forces are imposed, during systole and during diastole.
  • FIGS. 17-19 illustrate aortic valves comprising one or more alternative reinforcement strips.
  • proximal refers to a direction that is generally closest to the heart during a medical procedure
  • distal refers to a direction that is furthest from the heart during a medical procedure
  • FIGS. 1-2 a first embodiment of a stent structure 20 , which may be used in conjunction with an aortic valve prosthesis, is shown and described.
  • the stent structure 20 may be used in conjunction with an aortic valve 120 to form a completed aortic valve prosthesis 10 as shown in FIG. 9 below.
  • the stent structure 20 has a collapsed delivery state and an expanded deployed state, and generally comprises a proximal region 30 , a tapered region 50 , and a distal region 70 , as shown in FIGS. 1-2 .
  • a pattern of the stent structure 20 depicted in a flattened and collapsed state, is shown in FIG. 3 .
  • the stent structure 20 may be manufactured from a continuous cylinder into which a pattern may be cut by a laser or by chemical etching to produce slits in the wall of the cylinder. The resulting structure may then be heat set to give it a desired final configuration. As shown in FIGS. 1-2 , the final configuration may include a shape having a series of multiple closed cells.
  • the proximal region 30 of the stent structure 20 comprises a generally cylindrical shape having an expanded outer diameter d 1 .
  • the proximal region 30 is configured to be disposed at least partially within the aortic sinus, as shown in FIG. 10 below.
  • the distal region 70 of the stent structure 20 comprises a generally cylindrical shape having an expanded outer diameter d 2 , and is configured to be disposed at least partially within the ascending aorta.
  • the tapered region 50 generally bridges the change from diameter d 1 to diameter d 2 .
  • the proximal region 30 of the stent structure 20 may comprise multiple adjacent proximal apices 31 .
  • Each proximal apex 31 may comprise an end region 32 having an integral barb 33 formed therein, as shown in FIG. 4 .
  • the barb 33 may be formed by laser cutting a desired barb shape into the end regions 32 .
  • a slit 34 therefore is formed into each end region 32 after the desired barb shape is formed, as shown in FIG. 4 .
  • a main body of the barb 33 may be bent in a radially outward direction with respect to the end region 32 .
  • the angle may comprise any acute angle, or alternatively may be substantially orthogonal or obtuse.
  • the barb 33 may be sharpened, for example, by grinding the tip of the barb, to facilitate engagement at a target tissue site.
  • the proximal region 30 of the stent structure 20 further may comprise a plurality of closed cells 35 formed by multiple angled strut segments.
  • four angled strut segments 36 , 37 , 38 and 39 form one closed cell 35 , as shown in FIG. 1 .
  • a first proximal apex 31 extends distally and splits into first and second angled strut segments 36 and 37 , respectively, which are joined to one another at a junction 41 .
  • third and fourth angled strut segments 38 and 39 are joined at the junction 41 and extend distally therefrom, as shown in FIG. 1 .
  • the angled strut segments 36 - 39 of the cell 35 may be compressed such that they are substantially parallel to one another.
  • the first and second angled strut segments 36 and 37 each generally comprise a length L 1 , and each are generally disposed at an angle ⁇ 1 relative to a longitudinal axis L of the stent structure 20 , as shown in FIG. 1 .
  • the third and fourth angled strut segments 38 and 39 each generally comprise a length L 2 and each are generally disposed at an angle ⁇ 2 relative to the longitudinal axis L, as shown in FIG. 1 .
  • the closed cell 35 comprises a total length L 3 , representing the combined lengths L 1 and L 2 , as shown in FIG. 1 .
  • the length L 1 of the first and second angled strut segments 36 and 37 is greater than the length L 2 of the third and fourth angled strut segments 38 and 39 .
  • the length L 1 may be about 1.5 to about 4.0 times greater than the length L 2 .
  • a cross-sectional area of the first and second angled strut segments 36 and 37 may be greater than a cross-sectional area of the third and fourth angled strut segments 38 and 39 .
  • the cross-sectional area of the first and second angled strut segments 36 and 37 is about 4 times greater than the cross-sectional area of the third and fourth angled strut segments 38 and 39 .
  • the increased cross-sectional area of the first and second angled strut segments 36 and 37 causes these segments to primarily provide the radial force within the closed cells 35 , while the third and fourth angled strut segments 38 and 39 are mainly intended for connecting adjacent closed cells 35 and 55 a, instead of providing significant radial force.
  • the angle ⁇ 2 of the third and fourth angled strut segments 38 and 39 is greater than the angle ⁇ 1 of the first and second angled strut segments 36 and 37 . Since the first and second angled strut segments 36 and 37 are primarily providing the radial force, the angle ⁇ 1 is selected to achieve the desired radial force, while as noted above, the third and fourth angled strut segments 38 and 39 are mainly intended for connecting adjacent closed cells 35 and 55 a, and therefore yield a different angle ⁇ 2 for this different primary purpose. In one embodiment, the angle ⁇ 2 may be about 1.2 to 4.0 times greater than the angle ⁇ 1 .
  • each closed cell 35 comprises a generally spade-shaped configuration, as shown in FIGS. 1-2 .
  • the relative lengths and angles may be greater or less than depicted and/or provided in the exemplary dimensions disclosed herein.
  • the pattern of angled strut segments 36 - 39 may be repeated around the circumference of the proximal region 30 of the stent structure 20 .
  • the stent structure 20 may be formed into a continuous, generally cylindrical shape.
  • ten proximal apices 31 and ten closed cells 35 are disposed around the circumference of the proximal region 30 , although greater or fewer proximal apices and closed cells may be provided to vary the diameter and/or radial force characteristics of the stent.
  • the proximal region 30 may be flared slightly relative to the longitudinal axis L. In one example, a proximal end of each apex 31 may be bowed outward relative to a distal end of the same apex 31 . Such a flaring may facilitate engagement with the aortic sinus when implanted.
  • the tapered region 50 also comprises a plurality of closed cells.
  • four different closed cells 55 a, 55 b, 55 c and 55 d are provided along the length of the tapered region 50 .
  • Each of the closed cells 55 a - 55 d may comprise a slightly different shape, as shown in FIGS. 1-2 .
  • ten of each series of closed cells 55 a - 55 d are disposed around the circumference of the tapered region 50 , and the diameter of the tapered region 50 increases from the outer diameter d 1 to the outer diameter d 2 .
  • the first and second angled strut segments 56 and 57 each generally comprise a length L 4 and each are generally disposed at an angle relative to the longitudinal axis L that may be about the same as, or slightly greater or less than, the angle ⁇ 1 .
  • the third and fourth angled strut segments 58 and 59 each generally comprise a length L 5 and each are generally disposed at an angle relative to the longitudinal axis L that may be about the same as, or slightly greater or less than, the angle ⁇ 2 .
  • the closed cell 55 b comprises a total length L 6 , representing the combined lengths L 4 and L 5 , as shown in FIG. 1 .
  • the length L 4 of the first and second angled strut segments 56 and 57 is greater than the length L 5 of the third and fourth angled strut segments 58 and 59 .
  • the length L 4 may be about 1.1 to about 4 times greater than the length L 5 .
  • the total length L 6 of the closed cell 55 b of the tapered region 50 is greater than the total length L 3 of the closed cell 35 of the proximal region 30 , as shown in FIG. 1 .
  • the length of one or more individual struts of the tapered region 50 e.g., first and second angled strut segments 56 and 57 having length L 4 , may be longer than the total length L 3 of the closed cell 35 of the proximal region 30 .
  • the distal region 70 similarly comprises a plurality of closed cells.
  • two different closed cells 75 a and 75 b are provided along the length of the distal region 70 .
  • the closed cells 75 a and 75 b may comprise a different shape relative to one another, as shown in FIGS. 1-2 .
  • ten of each series of closed cells 75 a and 75 b are disposed around the circumference of the distal region 70 to form the overall outer diameter d 2 .
  • the most distal closed cell 75 b comprises four angled strut segments 76 , 77 , 78 and 79 , as shown in FIG. 1 .
  • the first and second angled strut segments 76 and 77 each generally comprise a length L 7 and each are generally disposed at an angle relative to the longitudinal axis L that may be about the same as, or slightly greater or less than, the angle ⁇ 1 .
  • the third and fourth angled strut segments 78 and 79 each generally comprise a length L 9 and each are generally disposed at an angle relative to the longitudinal axis L that may be about the same as, or slightly greater or less than, the angle ⁇ 2 .
  • a barbed region 80 having a barb 83 is disposed between the angled strut segments, as shown in FIG. 1 .
  • the barb 83 of the barbed region 80 may be formed integrally in the same manner as the barb 33 of the proximal region 30 , as shown in FIG. 4 , but preferably faces in a proximal direction.
  • the barbed region 80 is generally parallel to the longitudinal axis L of the stent structure 20 and comprises a length L 8 .
  • the cell 55 b comprises a total length L 10 , representing the combined lengths L 7 , L 8 and L 9 , as shown in FIG. 1 .
  • the length L 7 of the first and second angled strut segments 76 and 77 is greater than the length L 9 of the third and fourth angled strut segments 78 and 79 .
  • the length L 7 may be about 1.1 to about 4.0 times greater than the length L 9 .
  • the total length L 10 of the closed cell 75 b of the distal region 70 is greater than the total length L 6 of the closed cell 55 b of the tapered region 50 , which in turn is greater than the total length L 3 of the closed cell 35 of the proximal region 30 , as shown in FIG. 1 . Therefore, the lengths of individual closed cells increase along the stent structure from a proximal end 22 to a distal end 24 of the stent structure 20 .
  • the lengths of individual closed cells generally increase along to the stent structure 20 from the proximal end 22 to the distal end 24 , the forces imposed by the stent structure 20 along different regions may be varied for a patient's anatomy. Radial force and stiffness are a function of the individual cell lengths. Therefore, in the example of an aortic valve replacement, a relatively short length L 3 of the closed cell 35 of the proximal region 30 yields a relatively high radial force imposed upon the aortic sinus to allow for an enhanced and rigid attachment at this location.
  • a relatively long length L 10 of the closed cell 75 b of the distal region 70 yields a relatively low radial force imposed upon the ascending aorta, thereby facilitating a flexible contour at the distal region 70 that does not adversely impact the ascending aorta 105 .
  • radial force and stiffness are a function of the strut angles.
  • the individual struts 36 and 37 of the proximal region 30 may have a shallower strut angle relative to the individual struts 76 and 77 of the distal region 70 , i.e., the individual struts 36 and 37 may be more perpendicular to the longitudinal axis L of the device. Therefore, the angles of the individual struts 36 and 37 may contribute to a higher radial force at the proximal region 30 relative to the individual struts 76 and 77 of the distal region 70 .
  • an increased strut width may be provided at the proximal region 30 to promote a higher radial force relative to the strut width at the distal region 70 .
  • the stent structure 20 has different radial force properties at its proximal and distal regions 30 and 70 that beneficially interact with their associated regions into which they are implanted, e.g., the aortic sinus and the ascending aorta, respectively.
  • the lengths of individual cells may always increase relative to one another moving in a proximal to distal direction, i.e., each closed cell has an overall length that is greater than a length of every other closed cell that is disposed proximally thereof.
  • adjacent cells may comprise about the same length, or a proximal cell may comprise a lesser length than an adjacent distal cell. Therefore, while the lengths of individual angled strut segments generally increase in a proximal to distal direction, it is possible that some of the individual angled strut segments of a more distal region may be smaller than a more proximally oriented region.
  • Expansion of the stent structure 20 is at least partly provided by the angled strut segments, which may be substantially parallel to one another in a compressed state of FIG. 3 , but may tend to bow outward away from one another in the expanded state shown in FIGS. 1-2 .
  • the stent structure 20 may be formed from any suitable material, and formed from a laser-cut cannula.
  • the stent structure 20 has a reduced diameter delivery state so that it may be advanced to a target location within a vessel or duct.
  • the struts of the stent may comprise a substantially flat wire profile or may comprise a rounded profile. As best seen in FIGS. 1-2 , the struts of the stent generally comprise a flat wire profile in this example.
  • the stent structure 20 may be manufactured from a super-elastic material.
  • the super-elastic material may comprise a shape-memory alloy, such as a nickel titanium alloy (nitinol).
  • the stent structure 20 comprises a self-expanding material such as nitinol, the stent may be heat-set into the desired expanded state, whereby the stent structure 20 can assume a relaxed configuration in which it assumes the preconfigured first expanded inner diameter upon application of a certain cold or hot medium.
  • the stent structure 20 may be made from other metals and alloys that allow the stent structure 20 to return to its original, expanded configuration upon deployment, without inducing a permanent strain on the material due to compression.
  • the stent structure 20 may comprise other materials such as stainless steel, cobalt-chrome alloys, amorphous metals, tantalum, platinum, gold and titanium.
  • the stent structure 20 also may be made from non-metallic materials, such as thermoplastics and other polymers.
  • some foreshortening of the stent structure 20 may occur during expansion of the stent from the collapsed configuration of FIG. 3 to the expanded deployed state of FIGS. 1-2 . Since the proximal region 30 of the stent structure 20 is deployed first, it is expected that such foreshortening is not problematic since a precise landing area of the distal region 70 within the ascending aorta is generally not needed, so long as solid contact is achieved.
  • the barbs 33 of the proximal region 30 are oriented in a distally-facing direction, whereas the barbs 83 of the distal region 70 are oriented in a proximally-facing direction.
  • additional or fewer barbs may be disposed at various locations along the stent structure 20 and may be oriented in the same or different directions.
  • integral and/or externally attached barbs may be used.
  • the aortic valve 120 generally comprises proximal and distal regions 130 and 170 , respectively, and a tapered region 150 disposed therebetween.
  • the aortic valve 120 comprises a delivery state in which it may be compressed for percutaneous implantation along with the stent structure 20 , and further comprises different states during systole and diastole. Generally, antegrade flow opens the aortic valve 120 while retrograde flow closes the aortic valve 120 .
  • phase of systole for the aortic valve 120 depicted in FIG. 7 , blood may flow through the opposing flat surfaces 172 and 174 at the distal end 170 of the aortic valve 120 .
  • opposing flat surfaces 172 and 174 at the distal end 170 of the aortic valve 120 are generally adjacent to one another to inhibit blood flow back through the valve.
  • the proximal region 130 generally comprises a cylindrical body having an outer diameter that is approximately equal to, or just less than, an expanded inner diameter of the proximal region 30 of the stent structure 20 .
  • the aortic valve 120 is disposed generally within the stent structure 20 such that the proximal region 130 is at least partially aligned with the proximal region 30 of the stent structure 20 .
  • the tapered region 150 of the aortic valve 120 may comprise two opposing flat surfaces 152 and 154 , as shown in FIGS. 5-6 .
  • the opposing flat surfaces 152 and 154 generally each comprise a proximal portion 156 in the form of a curved area that reduces the diameter of the proximal region 130 , and a distal portion 157 in the form of a wide flat panel that transitions into the distal region 170 , as shown in FIGS. 5-6 .
  • the distal region 170 of the aortic valve 120 may comprise a generally rectangular profile from an end view, i.e., looking at the device from a distal to proximal direction.
  • the distal region 170 comprises the opposing flat surfaces 172 and 174 noted above, which are separated by narrower flat sides 175 a and 175 b, as shown in FIGS. 5-6 .
  • the opposing flat surfaces 152 and 154 of the tapered region 150 generally transition into the opposing flat surfaces 172 and 174 of the distal region 170 , respectively.
  • the opposing flat surfaces 152 and 154 of the tapered region 150 are angled relative to both the proximal region 130 and the distal region 170 , as shown in FIGS. 5-6 .
  • the aortic valve 120 may comprise a biocompatible graft material is preferably non-porous so that it does not leak under physiologic forces.
  • the graft material may be formed of Thoralon® (Thoratec® Corporation, Pleasanton, Calif.), Dacron® (VASCUTEK® Ltd., Renfrewshire, Scotland, UK), a composite thereof, or another suitable material.
  • the graft material is formed without seams.
  • the tubular graft can be made of any other at least substantially biocompatible material including such fabrics as other polyester fabrics, polytetrafluoroethylene (PTFE), expanded PTFE, and other synthetic materials.
  • Naturally occurring biomaterials are also highly desirable, particularly a derived collagen material known as extracellular matrix.
  • An element of elasticity may be incorporated as a property of the fabric or by subsequent treatments such as crimping.
  • the aortic valve 120 is disposed generally within the stent structure 20 such that the proximal region 130 of the aortic valve 120 is at least partially aligned with the proximal region 30 of the stent structure 20 .
  • a proximal attachment portion 132 of the aortic valve 120 having a length x is disposed proximal to the proximal apices 31 of the stent structure 20 , as shown in FIG. 8 , then the proximal attachment portion 132 is folded externally over the proximal apices 31 , as shown in FIG. 9 .
  • the proximal attachment portion 132 then may be sutured or otherwise attached to the proximal apices 31 and/or any of the angled strut segments 36 - 39 , thereby securing a portion of the aortic valve 120 to the stent structure 20 to form a complete aortic prosthesis 10 , as depicted in FIG. 9 .
  • the barbs 33 of the stent structure 20 may protrude through the fabric of the proximal attachment portion 132 for engagement with targeted tissue.
  • the distal region 170 of the aortic valve 120 may extend within the tapered region 50 and/or the distal region 70 of the stent structure 20 , and may be generally centrally disposed therein, although the exact positioning of distal region 170 of the aortic valve 120 relative to the stent structure 20 may be varied as needed.
  • one or more reinforcement members described generally in FIGS. 11-19 below, may be coupled to the aortic valve 120 and/or the stent structure 20 to enhance structural integrity and/or functionality of the aortic prosthesis 10 .
  • the distal region 170 of the aortic valve 120 is disposed within the tapered region 50 and/or the distal region 70 of the stent structure 20 , which are positioned in the proximal ascending thoracic aorta above (distal to) the annulus and above the native aortic valve.
  • Previous valves are designed to occupy the aortic annulus; however, the unpredictable shape and diameter of the aortic annulus makes the valve unpredictable in shape and diameter, leading to asymmetric replacement valve movement, leakage and reduced durability.
  • the distal region 170 of the aortic valve 120 by moving the distal region 170 of the aortic valve 120 to a distally spaced-apart location relative to the native aortic valve, i.e., the unpredictable shape and diameter of the aortic annulus have less impact upon the spaced-apart distal region 170 of the aortic valve 120 , and therefore the distal region 170 is less subject to asymmetric valve movement and leakage, and may have increased durability.
  • proximal and tapered regions 130 and 150 can vary without significantly affecting flow or valve function at the distal region 170 . While the distal region 170 of the valve 120 is shown having a generally rectangular shape, a tricuspid-shaped distal region of the valve may be provided, in which case the tapered region 150 may be omitted or altered to accommodate such a tricuspid-shaped distal region.
  • FIG. 10 a partial cut-away view of a heart 102 and an aorta 104 are shown.
  • the heart 102 may comprise an aortic valve 106 that does not seal properly. This defect of the aortic valve 106 allows blood to flow from the aorta 104 back into the left ventricle, leading to a disorder known as aortic regurgitation.
  • Also shown in FIG. 10 are a brachiocephalic trunk 112 , a left common carotid artery 114 , and a left subclavian artery 116 .
  • a portion of the aorta 104 referred to herein as an ascending aorta 105 is shown located between the aortic valve 106 and the brachiocephalic trunk 112 .
  • a patient's coronary arteries 117 and 118 are located distal to the aortic valve 106 .
  • the aortic prosthesis 10 is introduced into a patient's vascular system, delivered, and deployed using a deployment device, or introducer.
  • the deployment device delivers and deploys the aortic prosthesis 10 within the aorta at a location to replace the aortic valve 106 , as shown in FIG. 10 .
  • the deployment device may be configured and sized for endoluminal delivery and deployment through a femoral cut-down.
  • the aortic prosthesis 10 with the stent structure 20 in a radially collapsed state, may be inserted into a delivery catheter using conventional methods.
  • various other components may need to be provided in order to obtain a delivery and deployment system that is optimally suited for its intended purpose.
  • Zenith® Thoracic Aortic Aneurysm Endovascular Graft uses a delivery system that is commercially available from
  • Cook Inc. Bloomington, Ind., and may be suitable for delivering and deploying an aortic prosthesis in accordance with the present embodiments.
  • a trigger wire release mechanism for releasing a retained end of the stent structure 20 of the aortic prosthesis 10 .
  • the trigger wire arrangement includes at least one trigger wire extending from a release mechanism through the deployment device, and the trigger wire is engaged with selected locations of the stent structure 20 . Individual control of the deployment of various regions of the stent structure 20 enables better control of the deployment of the aortic prosthesis 10 as a whole.
  • stent structure 20 is generally described as a self-expanding framework herein, it will be appreciated that a balloon-expandable framework may be employed to accomplish the same functionality. If a balloon-expandable stent structure is employed, then a suitable balloon catheter is employed to deliver the aortic prosthesis as generally outlined above. Optionally, after deployment of a self-expanding stent structure 20 , a relatively short balloon expandable stent may be delivered and deployed inside of the proximal region 30 of the stent structure 20 to provided added fixation at the location of the aortic sinus.
  • the aortic prosthesis 10 Upon deployment, the aortic prosthesis 10 is positioned as generally shown in FIG. 10 .
  • a relatively high radial force is imposed by the closed cells 35 of the proximal region 30 upon the aortic sinus 106 to allow for an enhanced and rigid attachment at this location.
  • a relatively low radial force is imposed by the closed cells 75 a and 75 b of the distal region 70 upon the ascending aorta 105 , thereby facilitating a flexible contour at the distal region that does not adversely impact the ascending aorta 105 .
  • the aortic prosthesis 10 When the aortic prosthesis 10 is implanted, sufficient flow into the coronary arteries 117 and 118 is maintained during retrograde flow. In particular, after blood flows through the distal region 170 of the aortic valve 120 , blood is allowed to flow adjacent to the outside of the tapered central region 150 of the aortic valve 120 and into the coronary arteries 117 and 118 , i.e., through the open individual cells of the stent structure 20 .
  • the proximal and distal regions 30 and 70 may be configured so that the radial forces exerted upon the coronary sinus 105 and the ascending aorta 105 , respectively, are enough to hold the stent structure 20 in place.
  • each of the members of the aortic prosthesis 10 may vary.
  • the size of a preferred prosthetic device is determined primarily by the diameter of the vessel lumen (preferably for a healthy valve/lumen combination) at the intended implant site, as well as the desired length of the overall stent and valve device.
  • an initial assessment of the location of the natural aortic valve in the patient is determinative of several aspects of the prosthetic design. For example, the location of the natural aortic valve in the patient will determine the dimensions of the stent structure 20 and the aortic valve 120 , the type of valve material selected, and the size of deployment vehicle.
  • the aortic valve 120 replaces the function of the recipient's native damaged or poorly performing aortic valve.
  • the aortic valve 120 allows blood flow when the pressure on the proximal side of the aortic valve 120 is greater than pressure on the distal side of the valve.
  • the artificial valve 120 regulates the unidirectional flow of fluid from the heart into the aorta.
  • FIGS. 11-19 various reinforcement members are described that may be coupled to the aortic valve 120 and/or the stent structure 20 to enhance structural integrity and/or functionality of the aortic prosthesis 10 .
  • the normal, native aortic valve is suspended from above through its attachment to the walls of the coronary sinus, and suspended aortic valves resist the forces created by diastolic pressure on closed leaflets through attachment to downstream support.
  • the various reinforcement members of FIGS. 11-19 are intended to reinforce the aortic valve 120 , and in particular, prevent in-folding or “prolapse” of the valve during diastole.
  • a first embodiment of reinforcement members comprises a plurality of suspension ties 180 a - 180 d that are coupled between the tapered region 150 of the aortic valve 120 and the tapered region 50 of the stent structure 20 .
  • blood may flow through the opposing flat surfaces 172 and 174 at the distal end 170 of the aortic valve 120 , and the suspension ties 180 a - 180 d are relatively slack allowing for normal opening of the aortic valve 120 .
  • opposing flat surfaces 172 and 174 at the distal end 170 of the aortic valve 120 are generally adjacent to one another to inhibit blood flow back through the valve, while the suspension ties 180 a - 180 d become more taut and prevent prolapse of the aortic valve 120 when retrograde flow is imposed upon the exterior surfaces of the valve, as depicted in the finite element analysis simulation of FIG. 12 .
  • the suspension ties 180 a - 180 d advantageously provide a safety mechanism by which prolapse is avoided during retrograde flow.
  • the suspension ties 180 a - 180 d may be molded into the aortic valve 120 in the manner that fiber reinforcements are molded into a graft structure, and further may be coupled to one or more struts of the stent structure 20 using sutures 198 or another suitable coupling member that does not impede expansion of the stent structure 20 . While first ends of the suspension ties 180 a - 180 d are shown coupled to the tapered region 150 of the aortic valve 120 , they may alternatively, or additionally, be coupled to another location, such as the distal region 170 .
  • suspension ties 180 a - 180 d are shown coupled to the tapered region 50 of the stent structure 20 , they may alternatively, or additionally, be coupled to another location, such as the distal region 70 . While four exemplary suspension ties 180 a - 180 d are shown, greater or fewer suspension ties may be used, and their positioning may be varied as noted above, to achieve the desired functionality and reduce potential prolapse of the aortic valve 120 .
  • the angles ⁇ 3 of the suspension ties 180 a - 180 d relative to the longitudinal axis L, as shown in FIG. 13 may be between about 40-80 degrees when relatively slack. However, it will be appreciated the angles ⁇ 3 may be greater or less than what is depicted in FIG. 13 .
  • the suspension ties 180 a - 180 d comprise a thickness of between about 0.002-0.02 inches, and are molded into a Thoralon® or Dacron® coating. Other materials may be used, so long as the suspension ties 180 a - 180 d are non-thrombogenic, or coated with a non-thrombogenic material.
  • the aortic valve 120 can therefore be as long as necessary for optimal valve function, even if it is of a simple bicuspid design.
  • the length of the aortic valve 120 can be varied such that the distal region 170 of the aortic valve 120 is positioned at the desired location within the ascending thoracic aorta spaced-apart from the native aortic annulus.
  • a first reinforcement strip 185 a generally extends between a portion of the proximal region 130 , through one opposing flat surface 152 of the tapered region 150 , and to one opposing flat surface 172 of the distal region 170 , as shown in FIGS. 14-16 .
  • a second reinforcement strip 185 b is disposed about 90 degrees apart from the first reinforcement strip 185 a, and generally extends between a portion of the proximal region 130 towards one of the narrower flat sides 175 a.
  • a third reinforcement strip 185 c is disposed about 90 degrees apart from the first reinforcement strip 185 a, and generally extends between a portion of the proximal region 130 , through one opposing flat surface 154 of the tapered region 150 , and to one opposing flat surface 174 of the distal region 170 .
  • a fourth reinforcement strip is obscured in FIGS. 14-16 but may be disposed about 90 degrees apart from the second reinforcement strip 185 b and is a mirror image thereof.
  • opposing flat surfaces 172 and 174 at the distal end 170 of the aortic valve 120 are generally adjacent to one another to inhibit blood flow back through the valve, while the reinforcement strips 185 a - 185 d may become bowed radially inward along the tapered region 150 to prevent prolapse of the aortic valve 120 when retrograde flow is imposed upon the exterior surfaces of the valve.
  • the reinforcement strips 185 a - 185 c may snap between the states depicted in FIGS. 15-16 during systole and diastole, respectively, when the associated pressures are imposed upon the aortic valve 120 .
  • the reinforcement strips 185 a - 185 c advantageously provide a safety mechanism by which prolapse is avoided during retrograde flow.
  • the reinforcement strips 185 a - 185 c of FIGS. 14-16 comprise stainless steel or nitinol, though any suitable material to perform such functions may be used.
  • the reinforcement strips may comprise a thickness of about 0.002 to about 0.010 inches and may be molded into the material of the aortic valve 120 , or coupled externally thereto.
  • FIGS. 17-19 various alternative reinforcement strips are depicted.
  • at least one elliptical reinforcement strip 190 is coupled to a portion of the proximal region 130 of the aortic valve 120 and extends distally into the tapered region 150 , positioned generally between the opposing flat surfaces 152 and 154 of the tapered region 150 .
  • a first elliptical reinforcement strip 191 is coupled entirely to the flat surface 152 of the tapered region 150
  • a second longitudinal reinforcement strip 192 extends between the proximal region 130 and tapered region 150 and is positioned generally between the opposing flat surfaces 152 and 154 of the tapered region 150 .
  • FIG. 17 at least one elliptical reinforcement strip 190 is coupled to a portion of the proximal region 130 of the aortic valve 120 and extends distally into the tapered region 150 , positioned generally between the opposing flat surfaces 152 and 154 of the tapered region 150 .
  • a first elliptical reinforcement strip 191 is
  • a diamond-shaped reinforcement strip 193 is coupled between the proximal region 130 and the flat surface 152 of the tapered region 150 .
  • the reinforcement strips 190 - 193 of FIGS. 17-19 may snap between two states during systole and diastole.
  • the reinforcement strips 190 - 193 advantageously provide a safety mechanism by which prolapse is avoided during retrograde flow. While various exemplary reinforcement strip shapes and locations are shown in FIGS. 14-19 , the shapes and locations of the reinforcement strips may be varied, and greater or fewer strips may be used, without departing from the spirit of the present embodiments.
  • the stent structure 20 shown herein may be used in connection with different aortic valves, beside the aortic valve 120 .
  • various artificial valve designs may have two or three membranes, and may be arranged in various shapes including slots and flaps that mimic the natural functionality of an anatomical valve.
  • the aortic valve 120 shown herein may be used in conjunction with different stent structures.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
US13/286,407 2010-11-05 2011-11-01 Stent structures for use with valve replacements Abandoned US20120116496A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US13/286,407 US20120116496A1 (en) 2010-11-05 2011-11-01 Stent structures for use with valve replacements
US15/841,744 US10695171B2 (en) 2010-11-05 2017-12-14 Stent structures for use with valve replacements
US16/913,434 US11554011B2 (en) 2010-11-05 2020-06-26 Stent structures for use with valve replacements
US16/913,472 US11602428B2 (en) 2010-11-05 2020-06-26 Stent structures for use with valve replacements
US18/154,573 US11911270B2 (en) 2010-11-05 2023-01-13 Stent structures for use with valve replacements
US18/587,117 US12245936B2 (en) 2010-11-05 2024-02-26 Stent structures for use with valve replacements

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41054010P 2010-11-05 2010-11-05
US13/286,407 US20120116496A1 (en) 2010-11-05 2011-11-01 Stent structures for use with valve replacements

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/841,744 Continuation US10695171B2 (en) 2010-11-05 2017-12-14 Stent structures for use with valve replacements

Publications (1)

Publication Number Publication Date
US20120116496A1 true US20120116496A1 (en) 2012-05-10

Family

ID=45444504

Family Applications (6)

Application Number Title Priority Date Filing Date
US13/286,407 Abandoned US20120116496A1 (en) 2010-11-05 2011-11-01 Stent structures for use with valve replacements
US15/841,744 Active 2032-05-02 US10695171B2 (en) 2010-11-05 2017-12-14 Stent structures for use with valve replacements
US16/913,472 Active 2032-09-24 US11602428B2 (en) 2010-11-05 2020-06-26 Stent structures for use with valve replacements
US16/913,434 Active 2032-09-24 US11554011B2 (en) 2010-11-05 2020-06-26 Stent structures for use with valve replacements
US18/154,573 Active US11911270B2 (en) 2010-11-05 2023-01-13 Stent structures for use with valve replacements
US18/587,117 Active US12245936B2 (en) 2010-11-05 2024-02-26 Stent structures for use with valve replacements

Family Applications After (5)

Application Number Title Priority Date Filing Date
US15/841,744 Active 2032-05-02 US10695171B2 (en) 2010-11-05 2017-12-14 Stent structures for use with valve replacements
US16/913,472 Active 2032-09-24 US11602428B2 (en) 2010-11-05 2020-06-26 Stent structures for use with valve replacements
US16/913,434 Active 2032-09-24 US11554011B2 (en) 2010-11-05 2020-06-26 Stent structures for use with valve replacements
US18/154,573 Active US11911270B2 (en) 2010-11-05 2023-01-13 Stent structures for use with valve replacements
US18/587,117 Active US12245936B2 (en) 2010-11-05 2024-02-26 Stent structures for use with valve replacements

Country Status (4)

Country Link
US (6) US20120116496A1 (enExample)
EP (1) EP2489331B1 (enExample)
JP (1) JP6105196B2 (enExample)
AU (1) AU2011244968B2 (enExample)

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110022157A1 (en) * 2007-10-25 2011-01-27 Jacques Essinger Stents, Valved-Stents, and Methods and Systems for Delivery Thereof
US20120059486A1 (en) * 2008-06-20 2012-03-08 Vysera Biomedical Limited Esophageal valve
US20140142693A1 (en) * 2012-11-20 2014-05-22 Medtronic, Inc Valve Prosthesis Frames
WO2014149319A1 (en) * 2013-03-15 2014-09-25 W.L. Gore & Associates, Inc. Improved leaflet and valve apparatus
WO2015139998A1 (de) * 2014-03-21 2015-09-24 Epflex Feinwerktechnik Gmbh Fangdrahtinstrument mit fangdrahtstruktur aus rohrstück
US9216082B2 (en) 2005-12-22 2015-12-22 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9750603B2 (en) 2014-01-27 2017-09-05 Medtronic Vascular Galway Stented prosthetic heart valve with variable stiffness and methods of use
DE102016110410A1 (de) * 2016-06-06 2017-12-07 Acandis Gmbh & Co. Kg Stent und Herstellungsverfahren
US10258464B2 (en) 2012-03-22 2019-04-16 Symetis Sa Transcatheter stent-valves
US10314697B2 (en) 2014-08-18 2019-06-11 W. L. Gore & Associates, Inc. Frame with integral sewing cuff for prosthetic valves
US10342659B2 (en) 2014-09-15 2019-07-09 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
US10368984B2 (en) 2013-12-06 2019-08-06 W. L. Gore & Associates, Inc. Asymmetric opening and closing prosthetic valve leaflet
US10376359B2 (en) 2009-11-02 2019-08-13 Symetis Sa Aortic bioprosthesis and systems for delivery thereof
US10463478B2 (en) 2012-12-19 2019-11-05 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves
CN110495968A (zh) * 2014-06-18 2019-11-26 波士顿科学国际有限公司 胆道支架
US10639144B2 (en) 2012-12-19 2020-05-05 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US10660745B2 (en) 2012-12-19 2020-05-26 W. L. Gore & Associates, Inc. Methods for improved prosthetic heart valve with leaflet shelving
US10695171B2 (en) 2010-11-05 2020-06-30 Cook Medical Technologies Llc Stent structures for use with valve replacements
US10716662B2 (en) 2007-08-21 2020-07-21 Boston Scientific Limited Stent-valves for valve replacement and associated methods and systems for surgery
US10881507B2 (en) 2012-12-19 2021-01-05 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
US10959842B2 (en) 2017-09-12 2021-03-30 W. L. Gore & Associates, Inc. Leaflet frame attachment for prosthetic valves
US10966820B2 (en) 2012-12-19 2021-04-06 W. L. Gore & Associates, Inc. Geometric control of bending character in prosthetic heart valve leaflets
US10987218B2 (en) 2017-10-31 2021-04-27 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
US10993803B2 (en) 2011-04-01 2021-05-04 W. L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11020221B2 (en) 2017-09-27 2021-06-01 W. L. Gore & Associates, Inc. Prosthetic valve with expandable frame and associated systems and methods
US11039917B2 (en) 2012-12-19 2021-06-22 W. L. Gore & Associates, Inc. Geometric prosthetic heart valves
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
USD926322S1 (en) 2018-11-07 2021-07-27 W. L. Gore & Associates, Inc. Heart valve cover
US11090153B2 (en) 2017-10-13 2021-08-17 W. L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
US11109963B2 (en) 2017-09-27 2021-09-07 W. L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
US11123183B2 (en) 2017-10-31 2021-09-21 W. L. Gore & Associates, Inc. Prosthetic heart valve
US11129622B2 (en) 2015-05-14 2021-09-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
CN113507902A (zh) * 2019-01-17 2021-10-15 爱德华兹生命科学公司 用于假体心脏瓣膜的框架
US11154397B2 (en) 2017-10-31 2021-10-26 W. L. Gore & Associates, Inc. Jacket for surgical heart valve
US11166809B2 (en) 2012-07-25 2021-11-09 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US11229438B2 (en) 2017-06-28 2022-01-25 Cook Medical Technologies Llc Implantable medical device including valve member
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11439502B2 (en) 2017-10-31 2022-09-13 W. L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
US11457925B2 (en) 2011-09-16 2022-10-04 W. L. Gore & Associates, Inc. Occlusive devices
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11628056B2 (en) 2016-11-22 2023-04-18 Cook Medical Technologies Llc Graft for treating the distal aortic arch and descending aorta in type a patients
US11911258B2 (en) 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
US11992219B2 (en) 2021-06-10 2024-05-28 Cook Medical Technologies Llc Implantable medical device and assembly
US12115063B2 (en) 2012-07-27 2024-10-15 Edwards Lifesciences Corporation Multi-frame prosthetic valve apparatus and methods
US12121461B2 (en) 2015-03-20 2024-10-22 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
US20240407914A1 (en) * 2009-12-04 2024-12-12 Edwards Lifesciences Corporation Prosthetic valve having a multi-part frame
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant
US12178699B2 (en) 2012-12-19 2024-12-31 Edwards Lifesciences Corporation Multi-frame prosthetic heart valve
US12414854B2 (en) 2010-05-20 2025-09-16 Jenavalve Technology, Inc. Catheter system for introducing an expandable stent into the body of a patient
US12447014B2 (en) 2019-04-12 2025-10-21 Edwards Lifesciences Corporation Valve with multi-part frame and associated resilient bridging features
US12458517B1 (en) * 2024-05-06 2025-11-04 Neurovenous Technologies, LLC Tapered jugular stents for vascular interventions, and systems and devices thereof

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090276040A1 (en) * 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10285798B2 (en) 2011-06-03 2019-05-14 Merit Medical Systems, Inc. Esophageal stent
US8986368B2 (en) 2011-10-31 2015-03-24 Merit Medical Systems, Inc. Esophageal stent with valve
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
EP2854718B1 (en) 2012-06-05 2017-03-22 Merit Medical Systems, Inc. Esophageal stent
EP2964148A4 (en) 2013-03-05 2016-08-24 Merit Medical Systems Inc REINFORCED VALVE
WO2014145338A1 (en) 2013-03-15 2014-09-18 Navigate Cardiac Structures, Inc. Catheter-guided replacement valves apparatus and methods
WO2014150130A1 (en) 2013-03-15 2014-09-25 Merit Medical Systems, Inc. Esophageal stent
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
CN106456347B (zh) * 2014-03-18 2018-11-13 波士顿科学国际有限公司 减少肉芽和炎症的支架设计
US10631984B2 (en) 2015-12-15 2020-04-28 Neovasc Tiara Inc. Transseptal delivery system
CN108882981B (zh) 2016-01-29 2021-08-10 内奥瓦斯克迪亚拉公司 用于防止流出阻塞的假体瓣膜
AU2017361296B2 (en) 2016-11-21 2022-09-29 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
EP3672530A4 (en) 2017-08-25 2021-04-14 Neovasc Tiara Inc. SEQUENTIALLY INSERTED TRANSCATHETER MITRAL VALVE PROSTHESIS
CN112867468B (zh) * 2018-10-19 2024-08-23 爱德华兹生命科学公司 具有非圆柱形框架的假体心脏瓣膜
AU2019374743B2 (en) 2018-11-08 2022-03-03 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
AU2020211601B2 (en) * 2019-01-24 2023-08-17 Shockwave Medical, Inc. Flow modifying implants
CN113747863B (zh) 2019-03-08 2024-11-08 内奥瓦斯克迪亚拉公司 可取回假体递送系统
EP4659710A2 (en) 2019-04-01 2025-12-10 Neovasc Tiara Inc. Controllably deployable prosthetic valve
AU2020271896B2 (en) 2019-04-10 2022-10-13 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
US11779742B2 (en) 2019-05-20 2023-10-10 Neovasc Tiara Inc. Introducer with hemostasis mechanism
US11311376B2 (en) 2019-06-20 2022-04-26 Neovase Tiara Inc. Low profile prosthetic mitral valve
US12011349B2 (en) 2020-03-04 2024-06-18 Medtronic, Inc. Balloon expandable stent with lengthened commissure posts for transcatheter implantation of a cardiac valve prosthesis
WO2021206920A1 (en) 2020-04-10 2021-10-14 St. Jude Medical, Cardiology Division, Inc. Collapsible leaflets for prosthetic heart valves
CN115515530A (zh) * 2020-04-23 2022-12-23 W.L.戈尔及同仁股份有限公司 带瓣膜导管假体
JP2024508519A (ja) 2021-03-01 2024-02-27 エンドバスキュラー エンジニアリング，インコーポレイテッド 拡張可能な遠位端部を含む血栓症の治療のための吸引デバイス、並びにそのシステム及び方法
US12053192B2 (en) 2022-09-01 2024-08-06 Endovascular Engineering, Inc. Systems, devices, and methods for aspiration, including expandable structures and rotatable shafts

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US20060265056A1 (en) * 2005-05-13 2006-11-23 Corevalve, Inc. Heart valve prosthesis and methods of manufacture and use
US20080039891A1 (en) * 2004-01-22 2008-02-14 Rex Medical Vein filter
US20100094411A1 (en) * 2008-10-13 2010-04-15 Vector Technologies, Ltd. Prosthetic valve having tapered tip when compressed for delivery
US20120053676A1 (en) * 2009-05-07 2012-03-01 Ku David N Implantable Prosthetic Vascular Valves

Family Cites Families (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS495434B1 (enExample) 1969-06-12 1974-02-07
US4222126A (en) 1978-12-14 1980-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare Unitized three leaflet heart valve
US4994077A (en) 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
DK124690D0 (da) 1990-05-18 1990-05-18 Henning Rud Andersen Klapprotes til implantering i kroppen for erstatning af naturlig klap samt kateter til brug ved implantering af en saadan klapprotese
US5755782A (en) 1991-01-24 1998-05-26 Autogenics Stents for autologous tissue heart valve
US5397351A (en) 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
WO1998032412A2 (en) 1997-01-24 1998-07-30 Scimed Life Systems Inc Bistable spring construction for a stent and other medical apparatus
US6245102B1 (en) 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US6258120B1 (en) 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
FR2764810B1 (fr) 1997-06-20 1999-08-13 Ela Medical Sa Dispositif et procede pour le traitement des troubles du rythme auriculaire
US5855600A (en) 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design
US6120534A (en) 1997-10-29 2000-09-19 Ruiz; Carlos E. Endoluminal prosthesis having adjustable constriction
US6254642B1 (en) * 1997-12-09 2001-07-03 Thomas V. Taylor Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
US6494090B1 (en) 1998-05-05 2002-12-17 Pierburg Ag Air-mass sensor
EP1121067A1 (en) 1998-10-13 2001-08-08 Ventrica, Inc. Devices and methods for use in performing transmyocardial coronary bypass
US6168619B1 (en) 1998-10-16 2001-01-02 Quanam Medical Corporation Intravascular stent having a coaxial polymer member and end sleeves
CA2289169A1 (en) 1998-11-11 2000-05-11 Ogawa Spring Co., Ltd. Stent, manufacturing method thereof and indwelling method thereof
FR2788217A1 (fr) * 1999-01-12 2000-07-13 Brice Letac Valvule prothetique implantable par catheterisme, ou chirurgicalement
US6364905B1 (en) 1999-01-27 2002-04-02 Sulzer Carbomedics Inc. Tri-composite, full root, stentless valve
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
HK1050470A1 (zh) 1999-09-10 2003-06-27 E. Thorpe Patricia 用於铬静脉不足的血管内处理
US6440164B1 (en) 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
FR2800984B1 (fr) 1999-11-17 2001-12-14 Jacques Seguin Dispositif de remplacement d'une valve cardiaque par voie percutanee
US7195641B2 (en) * 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6409756B1 (en) 2000-01-24 2002-06-25 Edward G. Murphy Endovascular aortic graft
CA2661804C (en) 2000-01-31 2014-04-01 Cook Biotech Incorporated Stent valves and uses of same
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US6773454B2 (en) 2000-08-02 2004-08-10 Michael H. Wholey Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6482228B1 (en) 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
US20050182483A1 (en) 2004-02-11 2005-08-18 Cook Incorporated Percutaneously placed prosthesis with thromboresistant valve portion
US7798147B2 (en) * 2001-03-02 2010-09-21 Pulmonx Corporation Bronchial flow control devices with membrane seal
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
DE60216426T2 (de) 2001-03-28 2007-09-13 Cook Inc., Bloomington Modulare stentendoprothese
KR100393548B1 (ko) * 2001-06-05 2003-08-02 주식회사 엠아이텍 의료용 스텐트
WO2002100297A2 (en) 2001-06-08 2002-12-19 Rex Medical, L.P. Vascular device with valve for approximating vessel wall
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
FR2826863B1 (fr) 2001-07-04 2003-09-26 Jacques Seguin Ensemble permettant la mise en place d'une valve prothetique dans un conduit corporel
US7377938B2 (en) 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
FR2828091B1 (fr) 2001-07-31 2003-11-21 Seguin Jacques Ensemble permettant la mise en place d'une valve prothetique dans un conduit corporel
FR2828263B1 (fr) 2001-08-03 2007-05-11 Philipp Bonhoeffer Dispositif d'implantation d'un implant et procede d'implantation du dispositif
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
US20030176914A1 (en) 2003-01-21 2003-09-18 Rabkin Dmitry J. Multi-segment modular stent and methods for manufacturing stents
US7014653B2 (en) 2001-12-20 2006-03-21 Cleveland Clinic Foundation Furcated endovascular prosthesis
US6911040B2 (en) 2002-01-24 2005-06-28 Cordis Corporation Covered segmented stent
EP1487380B1 (en) 2002-03-25 2008-02-27 Cook Incorporated Branched vessel prothesis
US7125418B2 (en) 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
US7572286B1 (en) 2002-05-13 2009-08-11 Advanced Cardiovascular Systems, Inc. Stent assembly for the treatment of vulnerable plaque
EP1513470A2 (en) 2002-05-28 2005-03-16 The Cleveland Clinic Foundation Minimally invasive treatment system for aortic aneurysms
US7556643B2 (en) 2002-07-24 2009-07-07 Boston Scientific Scimed, Inc. Graft inside stent
KR100442330B1 (ko) 2002-09-03 2004-07-30 주식회사 엠아이텍 스텐트 및 이 스텐트의 제조방법
US7220274B1 (en) 2003-03-21 2007-05-22 Quinn Stephen F Intravascular stent grafts and methods for deploying the same
ATE481057T1 (de) 2003-05-28 2010-10-15 Cook Inc Ventilprothese mit gefässbefestigungsvorrichtung
CN1849102B (zh) 2003-07-08 2011-01-19 文托技术有限公司 用于主动脉瓣狭窄治疗中通过动脉输送的可植入式修复装置及其方法
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
DE10334868B4 (de) 2003-07-29 2013-10-17 Pfm Medical Ag Implantierbare Einrichtung als Organklappenersatz, dessen Herstellungsverfahren sowie Grundkörper und Membranelement dafür
WO2005011535A2 (en) 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
US20050075725A1 (en) 2003-10-02 2005-04-07 Rowe Stanton J. Implantable prosthetic valve with non-laminar flow
US7144421B2 (en) 2003-11-06 2006-12-05 Carpenter Judith T Endovascular prosthesis, system and method
US7261732B2 (en) 2003-12-22 2007-08-28 Henri Justino Stent mounted valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
AU2005231356A1 (en) 2004-03-31 2005-10-20 Med Institute, Inc. Endoluminal graft with a prosthetic valve
ITTO20050074A1 (it) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl Protesi valvola cardiaca
US7331991B2 (en) 2005-02-25 2008-02-19 California Institute Of Technology Implantable small percutaneous valve and methods of delivery
WO2006127412A1 (en) 2005-05-20 2006-11-30 The Cleveland Clinic Foundation Apparatus and methods for repairing the function of a diseased valve and method for making same
DE102005051849B4 (de) 2005-10-28 2010-01-21 JenaValve Technology Inc., Wilmington Vorrichtung zur Implantation und Befestigung von Herzklappenprothesen
WO2007067820A2 (en) 2005-12-09 2007-06-14 Edwards Lifesciences Corporation Improved anchoring system for medical implant
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
CN2817764Y (zh) 2006-01-16 2006-09-20 孔祥清 经皮主动脉瓣置换装置
US20070168013A1 (en) 2006-01-19 2007-07-19 Myles Douglas Vascular graft and deployment system
US7591848B2 (en) 2006-04-06 2009-09-22 Medtronic Vascular, Inc. Riveted stent valve for percutaneous use
US20070244546A1 (en) 2006-04-18 2007-10-18 Medtronic Vascular, Inc. Stent Foundation for Placement of a Stented Valve
EP2029055A2 (en) 2006-06-01 2009-03-04 Mor Research Applications Ltd. Methods and devices for treatment of cardiac valves
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
FR2906454B1 (fr) 2006-09-28 2009-04-10 Perouse Soc Par Actions Simpli Implant destine a etre place dans un conduit de circulation du sang.
CN101641061B (zh) * 2006-12-06 2013-12-18 美顿力科尔瓦有限责任公司 用于环锚固的自膨胀瓣膜的经心尖递送的系统和方法
JP5313928B2 (ja) 2007-02-05 2013-10-09 ボストン サイエンティフィック リミテッド 経皮的な弁およびシステム
EP2124826B2 (en) 2007-02-15 2020-09-23 Medtronic, Inc. Multi-layered stents
US8221505B2 (en) 2007-02-22 2012-07-17 Cook Medical Technologies Llc Prosthesis having a sleeve valve
US20080208325A1 (en) 2007-02-27 2008-08-28 Boston Scientific Scimed, Inc. Medical articles for long term implantation
EP2698129B1 (en) 2007-06-04 2022-11-09 St. Jude Medical, LLC Prosthetic heart valve
ATE555752T1 (de) * 2007-08-24 2012-05-15 St Jude Medical Aortenklappenprothesen
JP2010540190A (ja) 2007-10-04 2010-12-24 トリバスキュラー・インコーポレイテッド 低プロファイル経皮的送達のためのモジュラー式血管グラフト
EP2205183B1 (en) * 2007-10-25 2018-11-28 Symetis SA A system for replacing a cardiac valve
US8715337B2 (en) 2007-11-09 2014-05-06 Cook Medical Technologies Llc Aortic valve stent graft
US9180030B2 (en) 2007-12-26 2015-11-10 Cook Medical Technologies Llc Low profile non-symmetrical stent
AU2009271574B2 (en) * 2008-07-15 2015-05-21 St. Jude Medical, Inc. Axially anchoring collapsible and re-expandable prosthetic heart valves for various disease states
AU2010216373B2 (en) 2009-02-20 2015-04-30 St. Jude Medical, Inc. Devices and methods for collapsing prosthetic heart valves
US20100217382A1 (en) 2009-02-25 2010-08-26 Edwards Lifesciences Mitral valve replacement with atrial anchoring
EP2400924B1 (en) * 2009-02-27 2017-06-28 St. Jude Medical, Inc. Prosthetic heart valve
US8888836B2 (en) 2009-04-07 2014-11-18 Medtronic Vascular, Inc. Implantable temporary flow restrictor device
JP5744028B2 (ja) 2009-08-27 2015-07-01 メドトロニック，インコーポレイテッド 経カテーテル弁搬送システムおよび方法
US10034748B2 (en) 2009-09-18 2018-07-31 The Regents Of The University Of California Endovascular prosthetic heart valve replacement
EP2496181B1 (en) 2009-11-02 2017-08-30 Symetis SA Aortic bioprosthesis and systems for delivery thereof
KR101702417B1 (ko) 2009-11-09 2017-02-06 삼성전자주식회사 ＵＰｎＰ를 이용한 호 송수신 시스템에서 통화의 독점권을 부여하는 방법 및 장치
US10433956B2 (en) 2010-02-24 2019-10-08 Medtronic Ventor Technologies Ltd. Mitral prosthesis and methods for implantation
US20110208289A1 (en) 2010-02-25 2011-08-25 Endospan Ltd. Flexible Stent-Grafts
US9039759B2 (en) 2010-08-24 2015-05-26 St. Jude Medical, Cardiology Division, Inc. Repositioning of prosthetic heart valve and deployment
EP2444030A1 (en) * 2010-08-31 2012-04-25 Biotronik AG Medical valve implant for implantation in an animal body and/or human body
AU2011306028B2 (en) * 2010-09-20 2014-07-17 St. Jude Medical, Cardiology Division, Inc. Valve leaflet attachment in collapsible prosthetic valves
US20120116496A1 (en) 2010-11-05 2012-05-10 Chuter Timothy A Stent structures for use with valve replacements
US20120116498A1 (en) 2010-11-05 2012-05-10 Chuter Timothy A Aortic valve prostheses
US9566149B2 (en) 2010-11-16 2017-02-14 W. L. Gore & Associates, Inc. Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US20080039891A1 (en) * 2004-01-22 2008-02-14 Rex Medical Vein filter
US20060265056A1 (en) * 2005-05-13 2006-11-23 Corevalve, Inc. Heart valve prosthesis and methods of manufacture and use
US20100094411A1 (en) * 2008-10-13 2010-04-15 Vector Technologies, Ltd. Prosthetic valve having tapered tip when compressed for delivery
US20120053676A1 (en) * 2009-05-07 2012-03-01 Ku David N Implantable Prosthetic Vascular Valves

Cited By (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US10299922B2 (en) 2005-12-22 2019-05-28 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10265167B2 (en) 2005-12-22 2019-04-23 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10314701B2 (en) 2005-12-22 2019-06-11 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9216082B2 (en) 2005-12-22 2015-12-22 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9839515B2 (en) 2005-12-22 2017-12-12 Symetis, SA Stent-valves for valve replacement and associated methods and systems for surgery
US11896482B2 (en) 2007-02-12 2024-02-13 Boston Scientific Medical Device Limited Stent-valves for valve replacement and associated methods and systems for surgery
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US10716662B2 (en) 2007-08-21 2020-07-21 Boston Scientific Limited Stent-valves for valve replacement and associated methods and systems for surgery
US20110022157A1 (en) * 2007-10-25 2011-01-27 Jacques Essinger Stents, Valved-Stents, and Methods and Systems for Delivery Thereof
US20230017818A1 (en) * 2007-10-25 2023-01-19 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US11452598B2 (en) * 2007-10-25 2022-09-27 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US9839513B2 (en) * 2007-10-25 2017-12-12 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US12171657B2 (en) * 2007-10-25 2024-12-24 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US10219897B2 (en) 2007-10-25 2019-03-05 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US10709557B2 (en) * 2007-10-25 2020-07-14 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US20140277402A1 (en) * 2007-10-25 2014-09-18 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US8647381B2 (en) * 2007-10-25 2014-02-11 Symetis Sa Stents, valved-stents, and methods and systems for delivery thereof
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US12232957B2 (en) 2008-02-26 2025-02-25 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US20120059486A1 (en) * 2008-06-20 2012-03-08 Vysera Biomedical Limited Esophageal valve
US10376359B2 (en) 2009-11-02 2019-08-13 Symetis Sa Aortic bioprosthesis and systems for delivery thereof
US12409031B2 (en) * 2009-12-04 2025-09-09 Edwards Lifesciences Corporation Prosthetic valve having a multi-part frame
US20240407914A1 (en) * 2009-12-04 2024-12-12 Edwards Lifesciences Corporation Prosthetic valve having a multi-part frame
US12414854B2 (en) 2010-05-20 2025-09-16 Jenavalve Technology, Inc. Catheter system for introducing an expandable stent into the body of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US12447015B2 (en) 2010-05-25 2025-10-21 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US10695171B2 (en) 2010-11-05 2020-06-30 Cook Medical Technologies Llc Stent structures for use with valve replacements
US11602428B2 (en) 2010-11-05 2023-03-14 Cook Medical Technologies Llc Stent structures for use with valve replacements
US11911270B2 (en) 2010-11-05 2024-02-27 Cook Medical Technologies Llc Stent structures for use with valve replacements
US12245936B2 (en) 2010-11-05 2025-03-11 Cook Medical Technologies Llc Stent structures for use with valve replacements
US11554011B2 (en) 2010-11-05 2023-01-17 Cook Medical Technologies Llc Stent structures for use with valve replacements
US10993803B2 (en) 2011-04-01 2021-05-04 W. L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
US11457925B2 (en) 2011-09-16 2022-10-04 W. L. Gore & Associates, Inc. Occlusive devices
US10898321B2 (en) 2012-03-22 2021-01-26 Symetis Sa Transcatheter stent-valves
US10258464B2 (en) 2012-03-22 2019-04-16 Symetis Sa Transcatheter stent-valves
US11957573B2 (en) 2012-03-22 2024-04-16 Boston Scientific Medical Device Limited Relating to transcatheter stent-valves
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US11166809B2 (en) 2012-07-25 2021-11-09 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US11950999B2 (en) 2012-07-25 2024-04-09 Edwards Lifesciences Corporation Everting transcatheter valve and methods
US12115063B2 (en) 2012-07-27 2024-10-15 Edwards Lifesciences Corporation Multi-frame prosthetic valve apparatus and methods
US20140142693A1 (en) * 2012-11-20 2014-05-22 Medtronic, Inc Valve Prosthesis Frames
US10660745B2 (en) 2012-12-19 2020-05-26 W. L. Gore & Associates, Inc. Methods for improved prosthetic heart valve with leaflet shelving
US11826248B2 (en) 2012-12-19 2023-11-28 Edwards Lifesciences Corporation Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US10639144B2 (en) 2012-12-19 2020-05-05 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US12178699B2 (en) 2012-12-19 2024-12-31 Edwards Lifesciences Corporation Multi-frame prosthetic heart valve
US11872122B2 (en) 2012-12-19 2024-01-16 Edwards Lifesciences Corporation Methods for improved prosthetic heart valve with leaflet shelving
US11896481B2 (en) 2012-12-19 2024-02-13 Edwards Lifesciences Corporation Truncated leaflet for prosthetic heart valves
US10463478B2 (en) 2012-12-19 2019-11-05 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves
US12295835B2 (en) 2012-12-19 2025-05-13 Edwards Lifesciences Corporation Prosthetic valves, frames and leaflets and methods thereof
US12133795B2 (en) 2012-12-19 2024-11-05 Edwards Lifesciences Corporation Geometric control of bending character in prosthetic heart valve leaflets
US10966820B2 (en) 2012-12-19 2021-04-06 W. L. Gore & Associates, Inc. Geometric control of bending character in prosthetic heart valve leaflets
US11039917B2 (en) 2012-12-19 2021-06-22 W. L. Gore & Associates, Inc. Geometric prosthetic heart valves
US10881507B2 (en) 2012-12-19 2021-01-05 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
WO2014149319A1 (en) * 2013-03-15 2014-09-25 W.L. Gore & Associates, Inc. Improved leaflet and valve apparatus
US11911258B2 (en) 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
US12318281B2 (en) 2013-08-30 2025-06-03 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US10368984B2 (en) 2013-12-06 2019-08-06 W. L. Gore & Associates, Inc. Asymmetric opening and closing prosthetic valve leaflet
US10736738B2 (en) 2014-01-27 2020-08-11 Medtronic Vascular Galway Stented prosthetic heart valve with variable stiffness and methods of use
US11395736B2 (en) 2014-01-27 2022-07-26 Medtronic Vascular Galway Stented prosthetic heart valve with variable stiffness and methods of use
US11857413B2 (en) 2014-01-27 2024-01-02 Medtronic Vascular Galway Stented prosthetic heart valve with variable stiffness and methods of use
US12324736B2 (en) 2014-01-27 2025-06-10 Medtronic Vascular Galway Unlimited Company Stented prosthetic heart valve with variable stiffness and methods of use
US9750603B2 (en) 2014-01-27 2017-09-05 Medtronic Vascular Galway Stented prosthetic heart valve with variable stiffness and methods of use
CN106456199A (zh) * 2014-03-21 2017-02-22 艾普福莱克斯高精技术工厂有限责任公司 带有由管件形成的捕捉线结构的捕捉线装置
CN106456199B (zh) * 2014-03-21 2019-01-01 科洛普拉斯特公司 带有由管件形成的捕捉线结构的捕捉线装置
WO2015139998A1 (de) * 2014-03-21 2015-09-24 Epflex Feinwerktechnik Gmbh Fangdrahtinstrument mit fangdrahtstruktur aus rohrstück
US10478203B2 (en) 2014-03-21 2019-11-19 Coloplast A/S Snare instrument with snare structure formed from a tube section
US11504221B2 (en) 2014-06-18 2022-11-22 Boston Scientific Scimed Inc. Biliary stents and methods
US12310832B2 (en) 2014-06-18 2025-05-27 Boston Scientific Scimed, Inc. Biliary stents and methods
CN110495968A (zh) * 2014-06-18 2019-11-26 波士顿科学国际有限公司 胆道支架
US10314697B2 (en) 2014-08-18 2019-06-11 W. L. Gore & Associates, Inc. Frame with integral sewing cuff for prosthetic valves
US11065112B2 (en) 2014-08-18 2021-07-20 W. L. Gore & Associates, Inc. Frame with integral sewing cuff for prosthetic valves
US11471276B2 (en) 2014-09-15 2022-10-18 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
US10342659B2 (en) 2014-09-15 2019-07-09 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
US12121461B2 (en) 2015-03-20 2024-10-22 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US12343255B2 (en) 2015-05-01 2025-07-01 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11129622B2 (en) 2015-05-14 2021-09-28 W. L. Gore & Associates, Inc. Devices and methods for occlusion of an atrial appendage
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
DE102016110410B4 (de) 2016-06-06 2023-03-02 Acandis Gmbh Stent, Herstellungsverfahren und Behandlungssystem
DE102016110410A1 (de) * 2016-06-06 2017-12-07 Acandis Gmbh & Co. Kg Stent und Herstellungsverfahren
US11628056B2 (en) 2016-11-22 2023-04-18 Cook Medical Technologies Llc Graft for treating the distal aortic arch and descending aorta in type a patients
US12433745B2 (en) 2017-01-27 2025-10-07 Jenavalve Technology, Inc. Heart valve mimicry
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11229438B2 (en) 2017-06-28 2022-01-25 Cook Medical Technologies Llc Implantable medical device including valve member
US12059344B2 (en) 2017-09-12 2024-08-13 Edwards Lifesciences Corporation Leaflet frame attachment for prosthetic valves
US10959842B2 (en) 2017-09-12 2021-03-30 W. L. Gore & Associates, Inc. Leaflet frame attachment for prosthetic valves
US11986387B2 (en) 2017-09-27 2024-05-21 Edwards Lifesciences Corporation Prosthetic valves with mechanically coupled leaflets
US11020221B2 (en) 2017-09-27 2021-06-01 W. L. Gore & Associates, Inc. Prosthetic valve with expandable frame and associated systems and methods
US11857412B2 (en) 2017-09-27 2024-01-02 Edwards Lifesciences Corporation Prosthetic valve with expandable frame and associated systems and methods
US11109963B2 (en) 2017-09-27 2021-09-07 W. L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
US12064344B2 (en) 2017-10-13 2024-08-20 Edwards Lifesciences Corporation Telescoping prosthetic valve and delivery system
US11090153B2 (en) 2017-10-13 2021-08-17 W. L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
US12053374B2 (en) 2017-10-31 2024-08-06 Edwards Lifesciences Corporation Medical valve and leaflet promoting tissue ingrowth
US11439502B2 (en) 2017-10-31 2022-09-13 W. L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
US12201520B2 (en) 2017-10-31 2025-01-21 Edwards Lifesciences Corporation Prosthetic heart valve
US11123183B2 (en) 2017-10-31 2021-09-21 W. L. Gore & Associates, Inc. Prosthetic heart valve
US11974916B2 (en) 2017-10-31 2024-05-07 Edwards Lifesciences Corporation Jacket for surgical heart valve
US12279954B2 (en) 2017-10-31 2025-04-22 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
US11154397B2 (en) 2017-10-31 2021-10-26 W. L. Gore & Associates, Inc. Jacket for surgical heart valve
US10987218B2 (en) 2017-10-31 2021-04-27 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
USD926322S1 (en) 2018-11-07 2021-07-27 W. L. Gore & Associates, Inc. Heart valve cover
US12029644B2 (en) * 2019-01-17 2024-07-09 Edwards Lifesciences Corporation Frame for prosthetic heart valve
CN113507902A (zh) * 2019-01-17 2021-10-15 爱德华兹生命科学公司 用于假体心脏瓣膜的框架
US12090046B2 (en) 2019-03-01 2024-09-17 Edwards Lifesciences Corporation Telescoping prosthetic valve with retention element
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
US12447014B2 (en) 2019-04-12 2025-10-21 Edwards Lifesciences Corporation Valve with multi-part frame and associated resilient bridging features
US11992219B2 (en) 2021-06-10 2024-05-28 Cook Medical Technologies Llc Implantable medical device and assembly
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant
US12458517B1 (en) * 2024-05-06 2025-11-04 Neurovenous Technologies, LLC Tapered jugular stents for vascular interventions, and systems and devices thereof
WO2025235376A1 (en) * 2024-05-06 2025-11-13 Neurovenous Technologies, LLC Tapered jugular stents for vascular interventions, and systems and devices thereof

Also Published As

Publication number Publication date
JP6105196B2 (ja) 2017-03-29
EP2489331A2 (en) 2012-08-22
US20200323631A1 (en) 2020-10-15
US12245936B2 (en) 2025-03-11
US10695171B2 (en) 2020-06-30
AU2011244968A1 (en) 2012-05-24
JP2012101061A (ja) 2012-05-31
US20230255759A1 (en) 2023-08-17
US11602428B2 (en) 2023-03-14
US20240307174A1 (en) 2024-09-19
US11554011B2 (en) 2023-01-17
US20200323632A1 (en) 2020-10-15
EP2489331B1 (en) 2017-06-28
US20180104054A1 (en) 2018-04-19
EP2489331A3 (en) 2012-11-07
AU2011244968B2 (en) 2014-04-17
US11911270B2 (en) 2024-02-27

Similar Documents

Publication Publication Date Title
US12245936B2 (en) Stent structures for use with valve replacements
EP2478869B1 (en) Aortic valve prosthesis
US20250073022A1 (en) Aortic valve stent graft
US10842618B2 (en) Endoluminal prosthesis comprising a valve and an axially extendable segment
JP2022140592A (ja) 可撓性交連フレーム
EP2777608B1 (en) Endoluminal prosthesis system
US9597180B2 (en) Transcatheter valve stent anchors
CN106999273A (zh) 具有无支撑瓣膜区段的分段式经导管瓣膜假体
MX2010008171A (es) Endoprotesis para valvulas cardiacas protesicas.
US11284996B2 (en) Attachment of leaflets to prosthetic heart valve
US20230068697A1 (en) Prosthetic device for implantation in the aortic valve region of a heart

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ROEDER, BLAYNE A.;GOPALAKRISHNAMURTHY, SHARATH;LEEWOOD, ALAN R.;SIGNING DATES FROM 20111103 TO 20111115;REEL/FRAME:027544/0220

Owner name: COOK MEDICAL TECHNOLOGIES LLC, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC.;REEL/FRAME:027544/0242

Effective date: 20111121

Owner name: COOK MEDICAL TECHNOLOGIES LLC, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHUTER, TIMOTHY A.;REEL/FRAME:027544/0118

Effective date: 20111103

STCV Information on status: appeal procedure

Free format text: COURT PROCEEDINGS TERMINATED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION